Inventor

ERICSSON ANNA

US43 patents

⚠️ This page may combine multiple inventors who share the name “ERICSSON ANNA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ERICSSON ANNA

FORMA THERAPEUTICS INC

Activating pyruvate kinase R

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors

Pyridinyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors

Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors

Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors

Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Activating pyruvate kinase R

Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors

Inhibiting CREB binding protein (CBP)

Activating pyruvate kinase R and mutants thereof

Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors

Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Quinolinone five-membered heterocyclic compounds as mutant-isocitrate dehydrogenase inhibitors

Inhibiting CREB binding protein (CBP)

Pyridin-2(1H)-one quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Inhibiting CREB binding protein (CBP)

Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitors

Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitors

Bromodomain inhibitors for androgen receptor-driven cancers

Inhibiting cyclic AMP-responsive element-binding protein (CREB)

NOVO NORDISK HEALTHCARE AG

Treating sickle cell disease with a pyruvate kinase R activating compound

Activating pyruvate kinase R

Activating pyruvate kinase R

Pyrrolopyrrole compositions as pyruvate kinase (PKR) activators

Treating sickle cell disease with a pyruvate kinase R activating compound

Activating pyruvate kinase R

FORMA TM2 INC

Quinolinone pyrimidines compositions as mutant-isocitrate dehydrogenase inhibitors

Phenyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Pyridinyl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

Fused-bicyclic aryl quinolinone derivatives as mutant-isocitrate dehydrogenase inhibitors

BRISTOL MYERS SQUIBB CO

Compounds having retinoid-like activity

Retinoid-like compounds

VALO EARLY DISCOVERY INC

Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors

VALO HEALTH INC

Pyrrolo and pyrazolopyrimidines as ubiquitin-specific protease 7 inhibitors